Acutaas Chemicals Limited

Acutaas Chemicals Limited, known as Ami Organics Limited at the time of its public issue, is a research and development driven manufacturer of specialty chemicals based in Gujarat. The company develops and produces advanced pharmaceutical intermediates and active pharmaceutical ingredients used in generic and new chemical entity drug formulations, alongside select performance and specialty chemical products. Its portfolio spans several therapeutic areas, built on an in-house synthesis and process research capability that supports both contract development work and its own intermediate product lines. The company operates manufacturing facilities in Gujarat and has built a customer base spanning roughly two dozen countries, serving pharmaceutical manufacturers that require regulated, quality-certified intermediates. Its plants and processes carry ISO 9001, ISO 14001 and ISO 45001 certifications along with USFDA and GMP approvals, reflecting the compliance standards expected by its regulated-market customers. The company completed its initial public offering in September 2021 and later changed its corporate name to Acutaas Chemicals Limited in 2025, continuing the same business under the new identity. In the years leading up to its listing the company grew steadily, with revenue and profit both expanding meaningfully between FY19 and FY21 on the back of rising demand for its pharma intermediate products. That growth trajectory, combined with its research-led product development model, positioned it among the more closely watched specialty chemical listings of its year, evidenced by the very strong investor demand its public offer attracted.

The company raised approximately Rs 171 crore from 20 anchor investors at Rs 610 per equity share on August 31, 2021, ahead of the public issue opening.